Appendix V of the QRD template has been updated. This appendix lists the details of the national reporting systems for communicating adverse reactions, which must be stated in the SmPC and the package leaflet.

In the most recently updated version of Appendix V (Version 20), the information for Luxembourg has been updated.

Source: European Medicines Agency


Share This